NAII

Business Context and Reporting Period

Company: Natural Alternatives International, Inc. (NAI)
Filing Type: Form 10-K (Annual Report)
Period Ended: June 30, 2007
Business Overview: NAI operates in two primary segments: Private Label Contract Manufacturing (providing manufacturing services for vitamins, minerals, and herbs) and Branded Products (marketing its own and third-party products via direct-to-consumer, retail, and catalog channels). The company operates manufacturing facilities in California and Switzerland.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 2.5% to $97.1 million. Private label contract manufacturing sales dropped 6% due to lower volumes from a new customer established in the prior year. This was partially offset by an 18% increase in branded products sales.
• Goodwill Impairment: The company recorded a non-cash goodwill impairment charge of $7.0 million in the fourth quarter of fiscal 2007. This charge was driven by lower expected future cash flows in the branded products segment, specifically due to declining sales of the "Pathway to Healing" product line following the discontinuation of Dr. Cherry's television program.
• Profitability Reversal: The company swung from a net income of $2.7 million in 2006 to a net loss of $5.3 million in 2007. Excluding the goodwill impairment, operating income decreased by 50% due to investments in the "As We Change" catalog and lower sales from the Pathway to Healing line.
• Debt Reduction: Total consolidated debt decreased significantly from $15.9 million to $4.6 million, primarily due to the repayment of $9.6 million on the working capital line of credit.

Guidance, Outlook, Risks, and Unusual Items

• Outlook: Management plans to focus on leveraging certified facilities, growing branded product lines, and improving operational efficiencies. They are evaluating alternative marketing programs to replace the discontinued television support for the Pathway to Healing line.
• Covenant Violations: As of June 30, 2007, the company was not in compliance with quarterly and annual net income covenants under its credit facility (requiring minimum net income of $1.00 quarterly and $750,000 annually). The lender has agreed to waive default rights as of June 30, 2007. Additionally, the company was late in filing its 10-K, violating a reporting covenant, which was also waived by the lender as of September 28, 2007.
• Customer Concentration Risk: Sales to the two largest customers (NSA International, Inc. and Mannatech, Incorporated) accounted for 71% of total net sales in 2007, up from 67% in 2006. The loss of either customer would materially affect financial results.
• Internal Control Weakness: Management identified a material weakness in internal controls regarding the annual goodwill impairment analysis, noting a lack of appropriate processes to develop forecasts in a timely manner, which contributed to a delay in filing the 10-K.

Investor Verification Checklist

• Covenant Compliance: Verify the status of the lender waivers regarding net income and reporting covenants and whether they remain in effect for the upcoming fiscal year.
• Customer Concentration: Assess the stability of relationships with NSA International and Mannatech, which collectively drive over 70% of revenue.
• Branded Product Viability: Evaluate the success of new marketing strategies for the "Pathway to Healing" line and the "As We Change" catalog to determine if the goodwill impairment was a one-time event or indicative of ongoing segment weakness.
• Internal Controls: Review management's remediation plan for the identified material weakness in internal controls over financial reporting.
• Liquidity: Confirm that the $7.5 million available under the line of credit and operating cash flows are sufficient to fund operations without requiring additional equity financing.